Anti-FTO antibody [EPR24440-12]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(16 Publications)
Rabbit Recombinant Monoclonal FTO antibody. Suitable for ICC/IF, Flow Cyt (Intra), WB and reacts with Mouse, Rat, Human samples. Cited in 16 publications.
View Alternative Names
KIAA1752, FTO, Alpha-ketoglutarate-dependent dioxygenase FTO, Fat mass and obesity-associated protein, U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO, U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO, mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO, mRNA N(6)-methyladenosine demethylase FTO, tRNA N1-methyl adenine demethylase FTO, m6A(m)-demethylase FTO
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-FTO antibody [EPR24440-12] (AB280081)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized NIH/3T3 cells labelling FTO with ab280081 at 1/50 (11.98 ug/ml) dilution, followed by ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) antibody at 1/1000 dilution (Green). Confocal image showing nuclear and weak cytoplasmic staining in NIH/3T3 cell line is observed.
ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control : Secondary antibody is ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) at 1/1000 dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-FTO antibody [EPR24440-12] (AB280081)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized NIH/3T3 (Mouse embryonic fibroblast) cells labelling FTO with ab280081 at 1/500 dilution (0.1ug)/ (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody.
- WB
Lab
Western blot - Anti-FTO antibody [EPR24440-12] (AB280081)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Exposure time : Lanes 1-2 : 15 seconds; Lanes 3-5 : 6 seconds; Lanes : 6-7 : 15 seconds.
All lanes:
Western blot - Anti-FTO antibody [EPR24440-12] (ab280081) at 1/1000 dilution
Lane 1:
NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 2:
C2C12 (mouse myoblasts myoblast) whole cell lysate at 20 µg
Lane 3:
HEK-293 (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 4:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 5:
HAP1 (human chronic myelogenous leukemia near-haploid cell line) whole cell lysate at 20 µg
Lane 6:
PC-12 (rat adrenal gland pheochromocytoma) whole cell lysate at 20 µg
Lane 7:
L6 (rat skeletal muscle myoblast) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 58 kDa
Observed band size: 60 kDa
false
- WB
Lab
Western blot - Anti-FTO antibody [EPR24440-12] (AB280081)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Exposure time : 3 minutes.
All lanes:
Western blot - Anti-FTO antibody [EPR24440-12] (ab280081) at 1/1000 dilution
Lane 1:
Mouse brain tissue lysate at 20 µg
Lane 2:
Mouse heart tissue lysate at 20 µg
Lane 3:
Rat brain tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 58 kDa
Observed band size: 60 kDa
false
- WB
Lab
Western blot - Anti-FTO antibody [EPR24440-12] (AB280081)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Exposure time : Lanes 1-2 : 15 seconds;Lane 3 : 48 seconds.
All lanes:
Western blot - Anti-FTO antibody [EPR24440-12] (ab280081) at 1/1000 dilution
Lane 1:
Human lung tissue lysate 20 at 20 µg
Lane 2:
Human kidney tissue lysate at 20 µg
Lane 3:
Human skeletal muscle tissue lysate at 20 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 58 kDa
Observed band size: 60 kDa
false
- WB
Lab
Western blot - Anti-FTO antibody [EPR24440-12] (AB280081)
Blocking and diluting buffer and concentration : 3% NFDM/TBST
Lanes 1-3 : Merged signal (red and green). Green - ab280081 observed at 60 kDa. Red - loading control ab8245 observed at 36 kDa.
ab280081 Anti-FTO antibody [EPR24440-12] was shown to specifically react with FTO in wild-type HAP1 cells. Loss of signal was observed when the knockout cell line was used. Wild-type and FTO knockout samples were subjected to SDS-PAGE. ab280081 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at 4℃ overnight at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-FTO antibody [EPR24440-12] (ab280081) at 1/1000 dilution
Lane 1:
Wild-type HAP1 (human chronic myelogenous leukemia near-haploid cell) whole cell lysate at 20 µg
Lane 2:
FTO knockout HAP1 (human chronic myelogenous leukemia near-haploid cell) whole cell lysate at 20 µg
Lane 3:
HEK-293 (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG H&L (IRDye® 800CW) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) and Goat Anti-Mouse IgG H&L (IRDye® 680RD) (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/10000 dilution
Predicted band size: 58 kDa
Observed band size: 60 kDa
false
Related conjugates and formulations (1)
-
Anti-FTO antibody [EPR24440-12] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FTO influences energy homeostasis and adipogenesis. It acts as an important player in metabolic regulation and gene expression by modulating the m6A RNA modification. While FTO operates largely on its own its demethylation activity may interact with other RNA binding proteins that recognize m6A-modified RNAs integrating it into larger regulatory frameworks for RNA metabolism and cellular responses.
Pathways
FTO is an important component in the regulation of energy balance and metabolism. The protein is closely associated with the mTOR signaling pathway which is essential for controlling cell growth proliferation and survival in response to nutrient availability. FTO also interacts with the leptin signaling pathway relating to its role in appetite regulation and energy expenditure.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (16)
Recent publications for all applications. Explore the full list and refine your search
Cell & bioscience 15:124 PubMed40877964
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC pharmacology & toxicology 26:79 PubMed40211323
2025
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 39:e70332 PubMed39831513
2025
Applications
Unspecified application
Species
Unspecified reactive species
Investigative ophthalmology & visual science 65:9 PubMed39504046
2024
Applications
Unspecified application
Species
Unspecified reactive species
Discover oncology 15:182 PubMed38782769
2024
Applications
Unspecified application
Species
Unspecified reactive species
BMC biology 22:104 PubMed38702712
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 24:121 PubMed38555451
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cardiovascular diagnosis and therapy 14:158-173 PubMed38434564
2024
Applications
Unspecified application
Species
Unspecified reactive species
CNS neuroscience & therapeutics 30:e14636 PubMed38430221
2024
Applications
Unspecified application
Species
Unspecified reactive species
PeerJ 12:e16740 PubMed38274331
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com